HU-WXAT@EC2701A

LEOCH INT'L

STARGLORY HLDGS

INTELLIMARK W27

BEST FOOD HLDG

GAOYU FINANCE

EXTREME VISION

TIAN TU CAPITAL

HSC RESOURCES

EPI (HOLDINGS)

LAP KEI ENGRG

02269

02359

WXXWY

44048

603259

MCHI

China Stocks Continue Slide on Iran War Uncertainty; Wuxi Apptec Slides 3% on Trump Tariffs

marketscreener

WUXI BIO

WUXI APPTEC

WuXi Biologics

WUXI BIO POFF-D

WuXi AppTec

iShares MSCI China

China Stocks Continue Slide on Iran War Uncertainty; Wuxi Apptec Slides 3% on Trump Tariffs

FTXG

603288

159736

159843

159735

513230

513070

09987

Goldman Sachs has added Yum China ADR, WuXi AppTec, and HAI TIAN stocks to the Asia-Pacific "Conviction Buy List," while removing Toyo Tire and MakeMyTrip from the list. The latest target prices include: Dongpeng Beverage RMB 300, Gu Ming HKD 36, HAI TIAN HKD 46.8, Yum China USD 57.7, WuXi AppTec HKD 149.7, Alibaba USD 186, etc

AASTOCKS

First Trust NASDAQ Food & Beverage

HAI TIAN

Tianhong CSI Food and Beverage ETF

China Merchants Guozheng Food and Beverage ETF

Yinhua CSI HK Equities Consumption Theme ETF

ChinaAMC CSI HK Connect Consumption Theme ETF

E Fund CSI HK Equities Consumption Theme ETF

YUM CHINA

Goldman Sachs adds Yum China ADR, WuXi AppTec, and HAI TIAN to the Asia-Pacific "Conviction Buy List"

513130

01070

EBIZ

00883

02513

06869

On April 1, the Hong Kong stock market saw a collective rise in major indices during intraday trading, with the Hang Seng Index up 2.39% and the Hang Seng Tech Index up 2.64%. The internet content and retail sectors performed strongly, with leading stocks such as Tencent Holdings and Alibaba-W significantly boosting market sentiment. The oil and gas sector, influenced by international oil prices, saw a contrarian pullback. Individual stocks like TCL ELECTRONICS and HANSOH PHARMA were active with robust trading volumes, while the market is closely watching macroeconomic data and changes in consumer confidence

- At midday on April 1, Hong Kong stocks rose, with the Hang Seng Index up 2.39% to 25,379.55 points, though it remains below recent highs.  
- The market observed significant movements in innovative sectors, with notable gains from companies such as Zhiyuan and TCL Electronics, while the energy sector faced pressure, highlighted by a drop in CNOOC shares.  
- Investor focus is shifting towards macroeconomic indicators like manufacturing PMI and unemployment rates amidst ongoing fluctuations in exports and trade.

Market Heartbeat

Huatai-PB CSOP Hang Seng Technology ETF(QDII)

TCL ELECTRONICS

Global X E-commerce ETF

VanEck Retail ETF

CSOP HS TECH

KraneShares 2x Long BABA Daily ETF

BABA 2x Long Daily ETF - GraniteShares

Tianhong Hang Seng TECH ETF(QDII)

TENCENT

CI-LEAP@EC2612A

LEAPMOTOR

SUN HUNG KAI CO

HANSOH PHARMA

CNOOC

KNOWLEDGE ATLAS

YOFC

XIAOMI-W

BYD COMPANY

MEITUAN

E Fund CSI HK Connect Internet ETF

Alibaba

SPDR S&P Retail ETF

BABA-W

Hong Kong Stocks Intraday | Hang Seng Index Rises 2.39%, Internet Retail Strong

China Renaissance has maintained a Buy rating on WuXi AppTec Co., Ltd. Class H (2359) as of March 27, with a price target of HK$173.00. The stock closed at HK$115.60. The analyst consensus is a Strong Buy with an average price target of HK$152.04, indicating a potential upside of 31.52%. J.P. Morgan also supports this with a Buy rating and a price target of HK$150.00.

Tip Ranks

China Renaissance Keeps Their Buy Rating on WuXi AppTec Co., Ltd. Class H (2359)

513120

159570

513700

159316

520690

159506

520880

520500

J.P. Morgan analyst Yang Huang has maintained a Buy rating on WuXi AppTec Co., Ltd. Class H (2359), setting a price target of HK$150.00. The analyst is ranked #528 out of 12,068 analysts according to TipRanks. The consensus among analysts for WuXi AppTec Co., Ltd. Class H is a Strong Buy, with a price target consensus of HK$146.84.

GF CSI HK Innovative Drugs Industry ETF(QDII)

China Universal CNI HK Connect Innovative Drugs Industry ETF

Penghua CSI HK Connect Health Care Composite ETF

E Fund Hang Seng SCHK Innovative Drug ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)

J.P. Morgan Remains a Buy on WuXi AppTec Co., Ltd. Class H (2359)

WuXi AppTec Earnings Call Signals Confident 2026 Path

First Trust NYSE Arca Biotech Index Fd

WuXi AppTec Earnings Call Signals Confident 2026 Path

159615

516500

159837

159892

588130

562050

510660

516930

512290

CICC released a report stating that WuXi AppTec's 2025 performance meets expectations, with revenue of 45.456 billion RMB, a year-on-year increase of 15.8%; net profit attributable to the parent company is 19.151 billion RMB, a year-on-year increase of 102.7%. It is expected that total revenue in 2026 will reach 51.3 billion to 53 billion RMB, with a continuous growth of operating business revenue by 18%-22%. The net profit forecasts for 2026 and 2027 are maintained at 17.03 billion RMB and 19.13 billion RMB, respectively, with A/H share ratings of "outperforming the industry," and target prices of 123.5 RMB and 135 HKD, respectively

China Southern Hang Seng Biotech ETF(QDII)

E Fund CSI 300 Health Care ETF

ChinaAMC CSI Biotechnology Theme ETF

ICBCCS SSE STAR Biology and Medicine ETF

Ping An CSI Medicine and Medical Device Innovation ETF

China Merchants CSI Biotechnology Theme ETF

Tianhong CNI BIOMEDICINE ETF

E Fund CSI Biotechnology Theme ETF

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

ChinaAMC SSE STAR Biology and Medicine ETF

Huaan Hang Seng Biotech ETF

Hwabao WP CSI Pharmaceuticals ETF

ChinaAMC SSE Health Care ETF Initiating Fund

Penghua SSE STAR Biology and Medicine ETF

Yinhua CSI Innovative Drugs Industry ETF

Minsheng Royal CSI Biotechnology Theme ETF

Guotai CSI Bio-medicine ETF

CITIC Securities: WuXi AppTec's performance last year met expectations, maintaining earnings forecast

513060

Goldman Sachs raised WuXi AppTec's target price to HKD 149.7, maintaining a "Buy" rating. The company reiterated its revenue growth guidance during the earnings conference, expecting a 22% to 26% increase in revenue from continuing operations this year. Management emphasized that the oral small molecule GLP-1 project will become an important growth driver, with an expectation that 70% of the existing orders can be converted into revenue. Both the TIDES business and small molecule CDMO business have good growth prospects. Goldman Sachs slightly adjusted its earnings per share forecast, raising the A-share target price from RMB 132.7 to RMB 137.3

Bosera Hang Seng Health Care ETF(QDII)

Goldman Sachs raises WuXi AppTec's target price to 149.7 yuan, maintaining a "Buy" rating

Citi raised WuXi AppTec's target price to HKD 156 and listed it as the industry favorite. Management expects revenue growth from continuing operations this year to be between 18% and 22%, or 22% to 26% at constant exchange rates. The TIDES business is expected to grow by 30% to 40%. Citi raised its revenue forecasts for the next two years by 2% and 5%, and introduced a forecast for 2028, maintaining a "Buy" rating

Citigroup raises WuXi AppTec's target price to 156 yuan, listing it as the industry's top pick

WuXi AppTec Sets 2025 AGM to Vote on Dividends, Board Slate and FX Hedging

WuXi AppTec Sets 2025 AGM to Vote on Dividends, Board Slate and FX Hedging

06181

00100

03750

01898

01088

01171

LAOPU GOLD(06181) rose 16.11%, with a trading turnover 2.7 Billion HKD, and a year-to-date rose 4.9%. YOFC(06869) rose 13.09%, with a trading turnover 5.5 Billion HKD, and a year-to-date rose 219.1%. CNOOC(00883) fell 3.48%, with a trading turnover 7.4 Billion HKD, and a year-to-date rose 38.2%. CATL(03750) fell 2.57%, with a trading turnover 2.2 Billion HKD, and a year-to-date rose 27.6%.

Top Gainers & Losers

LAOPU GOLD

MINIMAX-W

CATL

CHINA COAL

CHINA SHENHUA

YANKUANG ENERGY

Top 5 HK Stock Gainers/Losers (>100B) (3.24)

Hot trading industry trends on August 7 and related Hong Kong semiconductor stocks. Hong Kong semiconductor stocks opened lower in early trading but then surged strongly, with Innoscience gaining over 11%, and industry leader SMIC rising over 3%. Core logic: On the news front, on August 1, Innoscience officially responded to rumors of collaboration with NVIDIA. The announcement stated that the company has recently partnered with global AI technology leader NVIDIA to jointly promote the large-scale implementation of the 800VDC (800-volt direct current) power architecture in AI data centers. Clear signals of a cyclical bottom: Global semiconductor inventory reduction is nearing its end...

NVIDIA

SMIC

SMIC HK SDR 5to1

SJM HOLDINGS

MGM CHINA

FIT HON TENG

INNOCARE

InnoCare Pharma

XIAOMI-WR

Xiaomi HK SDR 2to1

Xiaomi Corporation

GALAXY ENT

Galaxy Entertainment Group

NAGACORP

WYNN MACAU

MELCO INT'L DEV

SANDS CHINA LTD

Sands China

CSPC PHARMA

INNOVENT BIO

COWELL

HUA HONG SEMI

Hua Hong

SHANGHAI FUDAN

FMSH

INNOSCIENCE

SOLOMON SYSTECH

TIGERMED

Tigermed

Apple

Hot Trades in Hong Kong Stocks (8.7)｜ Chip Stocks Rebound Strongly, Apple Supply Chain Follows; Xiaomi and Pharmaceuticals Retreat Under Pressure

Hong Kong stocks' innovative medicine sector surges 66%, three-pronged approach ignites the golden track

REMEGEN

RemeGen

3SBIO

DUALITYBIO-B

HENGRUI PHARMA

Hengrui Pharma

AKESO

JOINN

Hong Kong stocks' innovative drugs surge 66%! Three major catalysts ignite the 'golden track', can we still get on board in the second half of the year?

On July 11, the three major stock indices in Hong Kong rose together. In terms of sectors, technology stocks rose collectively, and securities and brokerage stocks mostly increased.

CPIC

ZA ONLINE

POP MART

MIXUE GROUP

GUMING

The Hang Seng Index is approaching its highest level in nearly 3 years, with Chinese brokerage, insurance, and stablecoin concept stocks remaining hot!

HU-WXAT@EC2701A(28006.HK)

HU-WXAT@EC2701A Stock Performance Chart

China Stocks Continue Slide on Iran War Uncertainty; Wuxi Apptec Slides 3% on Trump Tariffs

Goldman Sachs adds Yum China ADR, WuXi AppTec, and HAI TIAN to the Asia-Pacific "Conviction Buy List"

Hong Kong Stocks Intraday | Hang Seng Index Rises 2.39%, Internet Retail Strong

China Renaissance Keeps Their Buy Rating on WuXi AppTec Co., Ltd. Class H (2359)

J.P. Morgan Remains a Buy on WuXi AppTec Co., Ltd. Class H (2359)